Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate

被引:22
作者
Furutama, D [1 ]
Fukui, R
Amakawa, M
Ohsawa, N
机构
[1] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 569, Japan
[2] Kaken Pharmaceut Co Ltd, Kyoto 607, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1998年 / 1406卷 / 01期
关键词
receptor; androgen; estrogen; steroid; aging; atherosclerosis;
D O I
10.1016/S0925-4439(97)00085-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) an the most abundant steroids in humans, and their serum concentrations progressively decrease with age. Although relationships between DHEA(-S) and many age-related illnesses have been postulated, the mechanisms for their effects remain unknown, and specific receptors for these molecules have not been identified. In this paper, to investigate the role of DHEA(-S) in atherogenesis, we studied the proliferation and migration of a rabbit vascular smooth muscle cell line, SM-3, in the presence of DHEA(-S). Cellular proliferation was inhibited by DHEA-S, and to a lesser extent by DHEA. Modified Boyden's chamber assays revealed that DHEA-S inhibited the migration of SM-3 cells toward PDGF-BB. In cell attachment assays, DHEA-S inhibited the attachment of SM3 cells to fibronectin. It was suggested that the inhibitory effect of DHEA-S for SM-3 proliferation and migration was due to the decreased interaction with fibronectin. Scatchard analysis revealed the presence of two populations of DHEA-S binding sites in the nuclear fraction, and a smaller number in the cytosolic fraction. Since the dissociation constant of the higher affinity site was similar to the serum DHEA-S concentration in humans (K-d = 5.8 mu M), this binding site could be functional under physiologic conditions. These findings suggest that there may be receptor-mediated anti-atherogenic actions of DHEA-S. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 45 条
[1]   SIGNALING MECHANISMS IN THE REGULATION OF VASCULAR CELL-MIGRATION [J].
ABEDI, H ;
ZACHARY, I .
CARDIOVASCULAR RESEARCH, 1995, 30 (04) :544-556
[2]   The relationship of natural androgens to coronary heart disease in males: A review [J].
Alexandersen, P ;
Haarbo, J ;
Christiansen, C .
ATHEROSCLEROSIS, 1996, 125 (01) :1-13
[3]  
Araghinikam Mohsen, 1996, Life Sciences, V59, P147
[4]   EFFECTS OF DEHYDROEPIANDROSTERONE-SULFATE ON CELLULAR CALCIUM RESPONSIVENESS AND VASCULAR CONTRACTILITY [J].
BARBAGALLO, M ;
SHAN, J ;
PANG, PKT ;
RESNICK, LM .
HYPERTENSION, 1995, 26 (06) :1065-1069
[5]   The epidemiology of DHEAS and cardiovascular disease [J].
BarrettConnor, E ;
GoodmanGruen, D .
DEHYDROEPIANDROSTERONE (DHEA) AND AGING, 1995, 774 :259-270
[6]   THERAPEUTIC EFFECTS OF DEHYDROEPIANDROSTERONE (DHEA) IN DIABETIC MICE [J].
COLEMAN, DL ;
LEITER, EH ;
SCHWIZER, RW .
DIABETES, 1982, 31 (09) :830-833
[7]   THERAPEUTIC EFFECTS OF DEHYDROEPIANDROSTERONE METABOLITES IN DIABETES MUTANT MICE (C57BL/KSJ-DB/DB) [J].
COLEMAN, DL ;
LEITER, EH ;
APPLEZWEIG, N .
ENDOCRINOLOGY, 1984, 115 (01) :239-243
[8]   RECEPTOR-BINDING AND ELECTROPHYSIOLOGICAL EFFECTS OF DEHYDROEPIANDROSTERONE SULFATE, AN ANTAGONIST OF THE GABA(A) RECEPTOR [J].
DEMIRGOREN, S ;
MAJEWSKA, MD ;
SPIVAK, CE ;
LONDON, ED .
NEUROSCIENCE, 1991, 45 (01) :127-135
[9]   INHIBITION OF GROWTH OF HELA AND WI-38 CELLS BY DEHYDROEPIANDROSTERONE AND ITS REVERSAL BY RIBONUCLEOSIDES AND DEOXYRIBONUCLEOSIDES [J].
DWORKIN, CR ;
GORMAN, SD ;
PASHKO, LL ;
CRISTOFALO, VJ ;
SCHWARTZ, AG .
LIFE SCIENCES, 1986, 38 (16) :1451-1457
[10]   PHYSIOLOGICAL IMPORTANCE OF DEHYDROEPIANDROSTERONE [J].
EBELING, P ;
KOIVISTO, VA .
LANCET, 1994, 343 (8911) :1479-1481